Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Change in Receivables (2016 - 2025)

Historic Change in Receivables for Veracyte (VCYT) over the last 14 years, with Q3 2025 value amounting to -$425000.0.

  • Veracyte's Change in Receivables rose 7485.21% to -$425000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.9 million, marking a year-over-year decrease of 7961.57%. This contributed to the annual value of $6.4 million for FY2024, which is 26478.0% up from last year.
  • As of Q3 2025, Veracyte's Change in Receivables stood at -$425000.0, which was up 7485.21% from -$2.8 million recorded in Q2 2025.
  • In the past 5 years, Veracyte's Change in Receivables registered a high of $7.1 million during Q1 2025, and its lowest value of -$3.1 million during Q2 2023.
  • In the last 5 years, Veracyte's Change in Receivables had a median value of $763000.0 in 2023 and averaged $1.0 million.
  • Per our database at Business Quant, Veracyte's Change in Receivables skyrocketed by 167478.99% in 2021 and then crashed by 38372.46% in 2023.
  • Veracyte's Change in Receivables (Quarter) stood at $2.3 million in 2021, then plummeted by 93.92% to $139000.0 in 2022, then skyrocketed by 448.92% to $763000.0 in 2023, then tumbled by 360.94% to -$2.0 million in 2024, then soared by 78.65% to -$425000.0 in 2025.
  • Its last three reported values are -$425000.0 in Q3 2025, -$2.8 million for Q2 2025, and $7.1 million during Q1 2025.